Circulating biomarkers to monitor cancer progression and treatment
Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Due to intratumoral heterogeneity and selection of s...
| Autors principals: | , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Elsevier
2016-01-01
|
| Col·lecció: | Computational and Structural Biotechnology Journal |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2001037016300113 |